Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 127 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1261 9.6 months Malignant pleural mesothelioma 4 Chemotherapy
Charing Cross Hospital United Kingdom 5/2008
Treatment Details: Patients: This phase II study involved 63 patients with relapsed malignant pleural mesothelioma. Their median age was 59, ranging from 29 to 77 years old. The majority (93.6%) of patients
 
1262 9.6 months Advanced NSCLC 3 Chemotherapy
Tochigi Cancer Center Japan 7/2007
Treatment Details: Patients: This phase II study involved 40 patients with advanced non-small cell lung cancer. These patients had previously been treated with a platinum-based chemotherapy such as cisplatin
 
1263 9.6 months Stage III and IV NSCLC 4 Chemotherapy
Bucharest Oncology Institute Romania 8/2007
Treatment Details: Patients: This phase II trial involved 102 patients with stage III and IV non-small cell lung cancer. The patients were divided into two groups: one group had a mean age of 59, and the othe
 
1264 9.6 months Metastatic melanoma 4 Immunotherapy
St. Luke's Medical Center United States 9/2007
Treatment Details: Patients: This phase II trial involved twenty-six patients with metastatic melanoma. There were 12 men and 14 women. The median age was 45 years, ranging from 28-70. The patients’ diseas
 
1265 9.6 months Advanced NSCLC 5 Chemotherapy
The Sarah Cannon Cancer Center and Tennessee Oncology United States 9/2002
Treatment Details: Patients: This Phase II study involved a total of 267 patients with advanced (Stage IIIB and IV) non-small-cell lung carcinoma. Patients were divided into 4 groups: Group A contained 71 pat
 
1266 9.6 months Malignant Mesothelioma 5 Chemotherapy
University of Chicago Medical Center United States 11/1999
Treatment Details: Patients: This Phase II study involved 20 patients with malignant mesothelioma who could not be treated by surgery or radiation alone. Treatment: The treatment consisted of administration
 
1267 9.6 months SCLC 5 Chemotherapy
S.G. Moscati Hospital Italy 5/2012
Treatment Details: Patients: This study involved small-cell lung cancer patients who were divided into two separate treatment groups. Group A had 328 patients with a median age of 67 years and 77.7% male. G
 
1268 9.6 months GBM and Astrocytoma 4 Radiation
University of Heidelberg Germany 7/2012
Treatment Details: This study involved elderly patients with anaplastic astrocytoma or glioblastoma who were divided into two separate treatment groups. Group A had 195 patients with a median age of 72 years
 
1269 9.6 months Colorectal carcinoma 4 Chemotherapy
Hospital Universitario Central de Asturias Spain 10/2011
Treatment Details: Patients: This study involved colorectal cancer patients who had progressed after previous chemotherapy. Patients were separated into two separate treatment groups. Group A had 38 patient
 
1270 9.6 months Transitional cell cancer of the urothelium 4 Chemotherapy
Hormone
Massachusetts General Hospital United States 7/2006
Treatment Details: Patients: This phase II study involved 47 patients with transitional cell cancer of the urothelium, a type of bladder cancer, who had received prior chemotherapy. The median patient age wa
 
Page 127 of 187  | Previous Page  | Next Page